Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-011360)

Filing Details

Accession Number:: 0001209191-22-011360
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-02-18 17:01:35
Reporting Period:: 2022-02-16

Accepted Time:: 2022-02-18 17:01:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1654151	Deciphera Pharmaceuticals Inc.	DCPH	Pharmaceutical Preparations (2834)	200299725

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1713712	Lee Daniel Flynn	C/O Deciphera Pharmaceuticals, Inc. 200 Smith Street Waltham MA 02451	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-02-16	1,366	$9.05	47,866	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	230,435	Indirect	By Daniel L. Flynn Revocable Trust
Common Stock	91,020	Indirect	By Daniel L. Flynn Irrevocable Trust

Footnotes

This sale was to cover tax liabilities in the vesting of restricted stock.